Skip to content
Vaccine & Immunotherapy Center
 
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECHNOLOGIES
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABORATORIES
    • Alagpulinsa Lab
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • Diversity
  • NEWS
  • DONATE
  • VIC Ukraine
    • Recent Press
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECHNOLOGIES
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABORATORIES
    • Alagpulinsa Lab
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • Diversity
  • NEWS
  • DONATE
  • VIC Ukraine
    • Recent Press
Vaccine & Immunotherapy Center
 
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECHNOLOGIES
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABORATORIES
    • Alagpulinsa Lab
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • Diversity
  • NEWS
  • DONATE
  • VIC Ukraine
    • Recent Press
  • ABOUT
    • MISSION
    • Advisors
    • Management Team
    • Principal Investigators
    • collaborators
  • TECHNOLOGIES
    • Infectious Disease
    • Immuno-oncology
    • Regenerative Medicine & Immunotherapy
    • High Dimensional Immunology
  • LABORATORIES
    • Alagpulinsa Lab
    • Dai Lab
    • Dogan Lab
    • Gelfand Lab
    • Gemechu Lab
    • Mukerji Lab
    • Poznansky Lab
    • Reeves Lab
    • Sîrbulescu Lab
  • Diversity
  • NEWS
  • DONATE
  • VIC Ukraine
    • Recent Press

EpiVax and Massachusetts General Hospital Advance on T cell-Targeted Epitope Vaccine for Q Fever

  • Posted on June 2, 2022
Evaluation of a human T cell-targeted multi-epitope vaccine for Q fever in animal models of Coxiella burnetti immunity. This paper is the result of a collaboration with Epivax, Inc., the Oxford Vaccine Group, Colorado State University and VIC published in Frontiers in Immunology.
PR Newswire Link
EpiVax Website Link
FacebookTwitter

Recommended Posts

Nanna Sivamanoharan is an MD student at the University of Edinburgh Medical School who spent the summer working in the lab at VIC.
VIC Welcomes Summer Students for another Summer of Fruitful Research Work in the Lab
Recent FASEB publication from the VIC team presents a review on a potential comprehensive definition of a target product profile for optimizing islet cell transplantation for treating and potentially curing type 1 diabetes
Recent Publication in the Journal of Inflammation from Dr. Ruxandra Sîrbulescu
Vaccine & Immunotherapy Center
Accelerating discovery and development of new products addressing unmet clinical need.
Facebook-f Twitter Youtube

INFORMATION

  • CAREERS
  • Directions
  • Advisors
  • Management
  • Collaborators
  • Support VIC

CONTACT

149 13th Street, 5th Floor
Charlestown Navy Yard,
MA 02129-2020

Phone  :  1-617-643-2098
Email    :  VIC@partners.org

© 2023 VACCINE & IMMUNOTHERAPY CENTER. ALL RIGHTS RESERVED |  Site by OLP